在健康和疾病中的神经瘤亡
Peng Lei1, Tara Walker2, Scott Ayton3,4
1Department of Neurology and State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China. peng.lei@scu.edu.cn.
Nature reviews. Neuroscience
|May 19, 2025
概括
铁灭,一个由铁驱动的细胞死亡过程,在大脑 (神经铁灭) 中至关重要. 它影响神经退行和神经元重编程,涉及神经元,星细胞和微细胞之间的复杂相互作用.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 铁亡是依赖铁的细胞死亡,涉及脂质过氧化.
- 由于大脑的高脂质,铁和氧气含量,神经亡的研究非常重要.
- 神经元需要强大的抗氧化防御来防止膜损伤.
研究的目的:
- 探索铁死在大脑中的作用和机制.
- 了解铁亡对神经退行和神经元重编程的影响.
- 研究涉及星体细胞和微质细胞的神经费洛普托斯细胞间通信.
主要方法:
- 这项研究审查了关于铁和神经铁死亡的现有文献.
- 对神经细胞中铁亡的基础细胞和分子机制的分析.
- 检查 ferroptosis 中不同类型的大脑细胞之间的相互作用.
主要成果:
- 铁亡与神经退行性疾病和缺血事件有关.
- 神经元的代谢需求需要保护机制来防止脂质过氧化.
- 星球细胞支持神经元防御,而微质细胞可以传播损伤.
结论:
- 神经质亡是大脑健康和疾病的关键过程.
- 了解铁亡对于开发神经疾病治疗方法至关重要.
- 细胞间信号通路在神经瘤亡的病理生理学中至关重要.
相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Necrosis
3.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
3.8K
Disorders of the Nervous Tissue
1.0K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.0K
Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K


